ATE546157T1 - Anti-pecam-therapie zur unterdrückung von metastasen - Google Patents
Anti-pecam-therapie zur unterdrückung von metastasenInfo
- Publication number
- ATE546157T1 ATE546157T1 AT04810905T AT04810905T ATE546157T1 AT E546157 T1 ATE546157 T1 AT E546157T1 AT 04810905 T AT04810905 T AT 04810905T AT 04810905 T AT04810905 T AT 04810905T AT E546157 T1 ATE546157 T1 AT E546157T1
- Authority
- AT
- Austria
- Prior art keywords
- suppressing metastasis
- pecam
- therapy
- pecam therapy
- metastasis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51998603P | 2003-11-13 | 2003-11-13 | |
| PCT/US2004/037924 WO2005048938A2 (en) | 2003-11-13 | 2004-11-12 | Anti-pecam therapy for metastasis suppression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE546157T1 true ATE546157T1 (de) | 2012-03-15 |
Family
ID=34619413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04810905T ATE546157T1 (de) | 2003-11-13 | 2004-11-12 | Anti-pecam-therapie zur unterdrückung von metastasen |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7572443B2 (de) |
| EP (1) | EP1691836B1 (de) |
| JP (1) | JP4897490B2 (de) |
| AT (1) | ATE546157T1 (de) |
| CA (1) | CA2541709C (de) |
| ES (1) | ES2382942T3 (de) |
| WO (1) | WO2005048938A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012047664A1 (en) * | 2010-09-27 | 2012-04-12 | Sutter West Bay Hospital D/B/A California Pacific Medical Center | Anti-pecam therapy, compositions, methods, and uses |
| US20220033495A1 (en) * | 2018-08-20 | 2022-02-03 | Industry-Academic Cooperation Foundation, Yonsei University | Antibody for pure isolation of vascular endothelial cells and preparation method thereof |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| GB8823869D0 (en) * | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| DE3920358A1 (de) * | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| US5633425A (en) * | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| AU8507191A (en) * | 1990-08-29 | 1992-03-30 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5625126A (en) * | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5661016A (en) * | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5545806A (en) * | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| ATE255131T1 (de) | 1991-06-14 | 2003-12-15 | Genentech Inc | Humanisierter heregulin antikörper |
| DE69233528T2 (de) | 1991-11-25 | 2006-03-16 | Enzon, Inc. | Verfahren zur Herstellung von multivalenten antigenbindenden Proteinen |
| JPH0853351A (ja) * | 1994-08-11 | 1996-02-27 | Sagami Chem Res Center | 酵素阻害剤、血管新生抑制剤、および癌転移抑制剤 |
| US5744585A (en) * | 1995-03-16 | 1998-04-28 | Medenica; Rajko D. | Human monoclonal antibody against lung carcinoma |
| US5912160A (en) | 1995-08-22 | 1999-06-15 | Thomas Jefferson University | Gab1, Grb2 binding protein, and compositions for making and methods of using the same |
| US5968511A (en) * | 1996-03-27 | 1999-10-19 | Genentech, Inc. | ErbB3 antibodies |
| US6133426A (en) * | 1997-02-21 | 2000-10-17 | Genentech, Inc. | Humanized anti-IL-8 monoclonal antibodies |
| JP2000247949A (ja) * | 1999-02-26 | 2000-09-12 | Eisai Co Ltd | スルホンアミド含有インドール化合物 |
| IL145941A (en) * | 1999-04-28 | 2007-08-19 | Univ Texas | Compositions and methods for cancer treatment by selectively inhibiting vegf |
| PL202369B1 (pl) | 1999-08-27 | 2009-06-30 | Genentech Inc | Zastosowanie przeciwciała skierowanego przeciw ErbB2, zastosowanie przeciwciała skierowanego przeciw ErbB oraz zestaw zawierający to przeciwciało |
| JP4018854B2 (ja) * | 1999-10-28 | 2007-12-05 | 第一三共株式会社 | 抗悪性腫瘍薬 |
| JP2003523207A (ja) | 2000-01-25 | 2003-08-05 | ジェネンテック・インコーポレーテッド | Ｌｉｖ−１関連タンパク質、それをコードするポリヌクレオチド、及び癌の治療へのその利用 |
| EP1378752A4 (de) * | 2001-04-13 | 2004-08-04 | Chugai Pharmaceutical Co Ltd | Verfahren zur quantifizierung der antigenexpression |
| ES2366775T3 (es) | 2001-04-24 | 2011-10-25 | Merck Patent Gmbh | POLITERAPIA UTILIZANDO AGENTES ANTIANGIOGÉNICOS Y TNF(alfa). |
| GB0130832D0 (en) | 2001-12-22 | 2002-02-06 | Univ Reading | Modulation of the activity of the platelet endothelial cell adhesion molecule-1 (pecam-1) |
-
2004
- 2004-11-12 AT AT04810905T patent/ATE546157T1/de active
- 2004-11-12 WO PCT/US2004/037924 patent/WO2005048938A2/en not_active Ceased
- 2004-11-12 EP EP04810905A patent/EP1691836B1/de not_active Expired - Lifetime
- 2004-11-12 JP JP2006539934A patent/JP4897490B2/ja not_active Expired - Fee Related
- 2004-11-12 US US10/988,423 patent/US7572443B2/en not_active Expired - Fee Related
- 2004-11-12 CA CA2541709A patent/CA2541709C/en not_active Expired - Fee Related
- 2004-11-12 ES ES04810905T patent/ES2382942T3/es not_active Expired - Lifetime
-
2009
- 2009-07-02 US US12/497,011 patent/US20090285828A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1691836B1 (de) | 2012-02-22 |
| US7572443B2 (en) | 2009-08-11 |
| JP2007511531A (ja) | 2007-05-10 |
| ES2382942T3 (es) | 2012-06-14 |
| WO2005048938A3 (en) | 2005-10-06 |
| JP4897490B2 (ja) | 2012-03-14 |
| US20090285828A1 (en) | 2009-11-19 |
| EP1691836A4 (de) | 2008-02-13 |
| CA2541709A1 (en) | 2005-06-02 |
| WO2005048938A2 (en) | 2005-06-02 |
| CA2541709C (en) | 2013-06-04 |
| EP1691836A2 (de) | 2006-08-23 |
| US20050186213A1 (en) | 2005-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY142988A (en) | Novel aminobenzophenone compounds | |
| IL244803B (en) | Human anti-beta antibodies and their use | |
| EA200700175A1 (ru) | Композиции и способы лечения воспалительных заболеваний | |
| EA200501771A1 (ru) | Лиганды каннабиноидных рецепторов и их применения | |
| EA200900802A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
| NO20083002L (no) | Fremgangsmate for anvendelse av CD40-bindende forbindelser | |
| ATE267830T1 (de) | Als cox-hemmer verwendbare sulfonylphenylpyrazol- verbindungen | |
| CY1111622T1 (el) | Ανθρωποποιημενοι ανταγωνιστες anti-cmet | |
| DE602004020072D1 (de) | 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen | |
| BRPI0418251A (pt) | fosfonatos, monofosfonamidatos, bisfosfonamidatos para o tratamento de doenças virais | |
| ATE461217T1 (de) | Glp-1-verbindungen | |
| ATE526991T1 (de) | Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen | |
| DK1560812T3 (da) | Aminocyclohexyletherforbindelser og anvendelser deraf | |
| EA200501928A1 (ru) | Пирролодигидроизохинолины как ингибиторы pde10 | |
| DK1895017T3 (da) | Anvendelse af A33-antigener og JAM-IT | |
| NO20055741D0 (no) | Nye kjemiske forbindelser | |
| SE0301650D0 (sv) | Novel compounds | |
| ATE549024T1 (de) | Chinazolin-kaliumkanalhemmer | |
| ATE443044T1 (de) | Tace inhibitoren | |
| DE60325194D1 (de) | Methoden zur verwendung von lamellaren körpern für therapeutische zwecke | |
| ATE383874T1 (de) | Perylenequinonen zur anwendung als sonosensitizer | |
| DE602004019541D1 (de) | Cycloalkyläbü kondensierte indole | |
| TW200716132A (en) | Novel chemical compounds | |
| EP1691836A4 (de) | Anti-pecam-therapie zur unterdrückung von metastasen | |
| MXPA05009428A (es) | Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas. |